-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

701.P1.41 701. Experimental Transplantation: Basic and Translational: Poster I

Symposia: Experimental Transplantation: Basic and Translational Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 9, 2023: 5:30 PM-7:30 PM
Halls G-H (San Diego Convention Center)

Hajime Senjo, MD1, Daigo Hashimoto, MD, PhD2*, Satomi Okada, MD3*, Shimpei I Kubota, MD, PhD4*, Ayumu Ito, MD, PhD5*, Takashi Tanaka, MD5*, Yumika Saito, MD3*, Toru Miyajima, MD3*, Wenyu Li3*, Zixuan Zhang3*, Shinpei Harada6*, Yuta Hasegawa, MD, PhD3*, Hiroyuki Ohigashi, MD, PhD3*, Takahide Ara, MD, PhD3*, Yoshinori Hasegawa, PhD7*, Yoshihiro Inamoto, MD, PhD5, Masaaki Murakami, VMD, PhD4*, Takahiro Fukuda, MD, PhD5* and Takanori Teshima, M.D., Ph.D.8

1Department of Hematology, Hokkaido University, Kita-Ku, Japan
2Department of Hematology, Hokkaido University Hospital, Sapporo, Hokkaido, Japan
3Department of Hematology, Hokkaido University Faculty of Medicine and Graduate School of Medicine, Sapporo, Japan
4Molecular Psychoneuroimmunology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan
5Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan
6Department of Hematology, Hokkaido University Faculty of Medicine and Graduate School of Medicine, Sapporo City, Japan
7Department of Applied Genomics, Kazusa DNA Research Institute, Chiba, Japan
8Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan

Ximi Kevin Wang, MD, MSc1,2*, Ajna Uzuni, MPH, MA1*, Kirubel Belay, BSc1*, David W Harle, BBiomedSc1*, Christian A Gordillo, BSc3*, Rodney J Macedo, MD, PhD1,4*, Shami Chakrabarti, PhD1*, Lingting Shi, PhD5*, Michael Pressler, BSc5*, Joshua Fuller, BSc5*, Elham Azizi5,6* and Ran Reshef, MD, MSc7,8

1Columbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, NY
2Department of Medicine, Yale New Haven Health - Bridgeport Hospital, Bridgeport, CT
3Blood and Marrow Transplantation and Cell Therapy Program, Columbia University Irving Medical Center, New York, NY
4Department of Radiation Oncology, Albert Einstein College of Medicine, New York, NY
5Department of Biomedical Engineering, Columbia University, New York, NY
6Irving Institute for Cancer Dynamics, Columbia University, New York, NY
7Division of Hematology & Oncology, Columbia University Medical Center, New York
8Blood and Marrow Stem Cell Transplantation Program, Division of Hematology & Oncology, Columbia University Irving Medical Center, New York, NY

Emma Lauder1*, Anders Kiledal, PhD2*, Dongchang Zhao, PhD3*, Gregory Dick, PhD4* and Pavan Reddy, MD5

1University of Michigan, Ann Arbor, MI
2Department of Earth and Environmental Sciences, University of Michigan, Ann Arbor, MI
3Baylor College of Medicine, Houston, TX
4Rogel Cancer Center, University of Michigan, Ann Arbor, MI
5Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston

Xiaohui Kong, PhD1,2*, Bixin Wang, MD, PhD1,2*, Xiwei Wu, MD, PhD3*, Hyejin Cho3*, Moqian Zheng1,2*, Yuankun Zhang1,2*, Shanshan Tang, PhD1,2*, Qinjian Li1,4*, Ubaydah Nasri1*, Alyssa Wu1*, Hanjun Qin3*, Raju Pillai, MD5*, Ryotaro Nakamura, MD2, Paul J. Martin, MD6, Yuanzhong Chen, MD7* and Defu Zeng, MD1,2

1Department of Immunology and Theranostics, Arthur Riggs Institute of Diabetes and Metabolism Research, Beckman Research Institute of City of Hope, Duarte, CA
2Hematologic Malignancies and Stem Cell Transplantation Institute, City of Hope National Comprehensive Cancer Center, Duarte, CA
3Department of Integrative Genomics Core, Beckman Research Institute of City of Hope, Duarte, CA
4Army medical University affiliated Xinqiao Hospital, Chongqing, China
5Department of Pathology, City of Hope National Comprehensive Cancer Center, Duarte, CA
6Fred Hutchinson Cancer Center, Seattle, WA
7Fujian Medical University Center of Translational Hematology, Fujian Institute of Hematology, Fujian Medical University Union Hospital, Fuzhou, China

Hemendra Ghimire, PhD1*, Srideshikan Sargur Madabushi, PhD2, Ji Eun Lim, PhD2*, Guy Storme, MD, PhD3*, Amandeep Salhotra, MD4,5, Loredana Ruggeri, MD, PhD6*, Antonio Pierini, MD, PhD7*, Monzr M. Al Malki, MD4 and Susanta Hui, PhD2*

1Radiation Oncology, City of Hope National Medical Center, Covina, CA
2Radiation Oncology, City of Hope National Medical Center, Duarte, CA
3Department of Radiotherapy Universitair Ziekenhuis (UZ) Brussels, Brussels, Belgium
4Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
5St. Elizabeth's Medical Ctr., Boston, MA
6Department of Medicine and Surgery, University of Perugia, Perugia, Italy
7Department of Medicine and Surgery, Division of Hematology and Clinical Immunology, University of Perugia, Perugia, Italy

Yiwen Helen Li, MS1*, Shuhua Wang, MD1,2* and Edmund K. Waller, MD3

1Emory University School of Medicine, Atlanta, GA
2Emory University School of Medicine and Winship Cancer Institute, Atlanta, GA
3Department of Hematology and Medical Oncology, Emory University Winship Cancer Institute, Atlanta, GA

Rathan Kumar1, Lotus Neidermire-Colley2*, Charlie Spencer3*, David Aslaner3*, Yandi Gao1*, Simran Surana1*, Matthew W Gorr, PhD2*, Katiri Snyder1, Malith Karunasiri3*, Loren E Wold, PhD2*, Gideon Bollag, PhD4, Ben Powell5*, Hannah Choe, MD6 and Parvathi Ranganathan, PhD1

1The Ohio State University, Columbus, OH
2the Ohio State University, COLUMBUS, OH
3the Ohio State University, Columbus
4Opna Bio, LLC, South San Francisco, CA
5OPNA-Bio, San Francisco
6Division of Hematology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH

Gao Mengge1*, Jun Kong, MD2*, Yuqian Sun, MD2*, Zhidong Wang2*, Ting-Ting Han2*, Yu Wang, MD3*, Xiaosu Zhao4* and Xiao Jun Huang, MD2

1Peking University People's Hospital, Peking University Institute of Hematology, Beijing, FL, China
2Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China
3Peking University People’s Hospital, Beijing, China
4Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China

Fei Gao, MD1*, Hengwei Wu, MD1*, Xin Jin, MD1*, Jimin Shi1,2,3,4*, Yi Luo1,2,4,5, Yanmin Zhao, MD6* and He Huang1*

1Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
2Institute of Hematology, Zhejiang University, Hangzhou, China
3Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, China
4Zhejiang Laboratory for Systems & Precision Medicine, Zhejiang University, Hangzhou, China
5Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Zhejiang University, Hangzhou, China
6Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People's Republic of China, Hangzhou, China

Fahmin Basher, MD, PhD1, Jonathan Visentin, PharmD, PhD2*, Wei Jia, MD, PhD1*, Jonathan C Poe, PhD1*, Christina Sofian1*, Hsuan Su1*, Sonali Bracken, MD, PhD3*, Rachel Dicioccio4*, Itaevia Curry-Chisolm4*, Vincent T. Ho, MD5,6*, Vanja Sisirak, PhD7*, Mitchell Horwitz, MD8, Nelson J. Chao, MD1 and Stefanie Sarantopoulos, MD, PhD1

1Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, NC
2Bordeaux University, Bordeaux, FRA
3Division of Rheumatology and Immunology, Department of Medicine, Duke University Medical Center, Durham, NC
4Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, NC
5Harvard Medical School, Boston, MA
6Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
7ImmunoConcEpT, Bordeaux, FRA
8Adult Stem Cell Transplant Program, Division of Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, NC

Vijith Vijayan, PhD1, Hao Yan, PhD2*, Juliane Lohmeyer, PhD3*, Kaylin Prentiss, BS3*, Rachana Patil, MS3*, Giulia Barbarito, MS1*, Ivan Lopez, BS3*, Aly Elezaby, MD, PhD3*, Kolten Peterson, BS4*, Jeanette Baker, PhD2*, Nicolai Ostberg, MS3*, Alice Bertaina, MD, PhD5, Robert S. Negrin, MD6, Daria Mochly-Rosen, PhD3*, Kenneth I. Weinberg, MD7* and Bereketeab Haileselassie, MD1*

1Stanford University School of Medicine, Palo Alto, CA
2Department of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA
3Stanford University School of Medicine, Stanford, CA
4Stanford School of Medicine, Palo Alto
5Stanford University, Palo Alto, CA
6Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University School of Medicine, Stanford, CA
7Department of Pediatrics, Division of Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA

Rachael C Adams1,2,3*, Dylan Carter-Cusack3*, Genesis T Llanes3*, Christopher R Hunter3*, Janaki Manoja Vinnakota, PhD2,4*, Marc Ruitenberg, PhD5*, Jana Vukovic, PhD5,6*, Patrick Bertolino, PhD7*, Kirat K. Chand, PhD8*, Julie A. Wixey, PhD8,9*, Samuel P Nayler, PhD3*, Geoffrey R Hill, MD10,11, Scott N Furlan, MD12*, Robert Zeiser, MD2,13,14 and Kelli PA MacDonald, PhD3*

1Faculty of Medicine, The University of Queensland, Brisbane, Australia
2Department of Medicine I, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany
3QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia
4Albert-Ludwigs University, Faculty of Biology, Freiburg im Bresigau, Germany
5School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane, Australia
6Queensland Brain Institute, The University of Queensland, Brisbane, Australia
7Royal Prince Alfred Hospital, Centenary Institute and University of Sydney, AW Morrow Gastroenterology and Liver Centre, Newtown, Australia
8UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Australia
9Perinatal Research Centre, Royal Brisbane and Women’s Hospital, The University of Queensland, Brisbane, Australia
10Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA
11Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA
12Translational Science and Therapeutics, Fred Hutchinson Cancer Center, Seattle, WA
13University of Freiburg, CIBSS – Centre for Integrative Biological Signalling Studies, Freiburg im Bresigau, Germany
14German Cancer Consortium (DKTK), Partner site Freiburg; and German Cancer Research Center (DKFZ), Heidelberg, Germany

Ran Zhang, PhD1*, Zhenli Huang, PhD1*, Li Wang, MD1*, Weijie Cao, PhD1*, Donald Small, MD, PhD2, Ruiqi Zhu, PhD3*, Wei Shi, PhD3*, Zhongxing Jiang, MD4* and Linghui Xia3*

1Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
2Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD
3Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
4The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

Matt Christopher, MD, Vaishali Basu, PhD* and Gregory Mannino*

Washington University School of Medicine, St. Louis,, MO

*signifies non-member of ASH